Irish start-up Nuritas aims to speed up drug development with big data
The race is on to be the first company to market with a drug developed by artificial intelligence (AI), with Irish start-up Nuritas among those leading the charge.
Addressing attendees at an event at Dogpatch Labs in Dublin’s docklands recently, Nuritas founder and chief scientific officer Nora Khaldi outlined the impact AI will have on life sciences and how her company is helping to lead a revolution in health.
“AI has achieved a lot in many areas but very little so far in life sciences and true biology. I believe, though, that biology is the area where AI will have the largest impact over the next few years,” she said.
“I think it would be great for everyone who works in AI or computer science to focus on this area because it will be the most impactful for humankind,” Ms Khaldi added.
Nuritas uses data mining of molecules in food and food byproducts to identify supplements and new drugs. The company was founded by Ms Khaldi, a TCD-trained mathematician and bioinformatics specialist, in 2014 and was subsequently spun out of NovaUCD’s VentureLaunch accelerator programme.
Read more: http://bit.ly/2GfOBWd
Addressing attendees at an event at Dogpatch Labs in Dublin’s docklands recently, Nuritas founder and chief scientific officer Nora Khaldi outlined the impact AI will have on life sciences and how her company is helping to lead a revolution in health.
“AI has achieved a lot in many areas but very little so far in life sciences and true biology. I believe, though, that biology is the area where AI will have the largest impact over the next few years,” she said.
“I think it would be great for everyone who works in AI or computer science to focus on this area because it will be the most impactful for humankind,” Ms Khaldi added.
Nuritas uses data mining of molecules in food and food byproducts to identify supplements and new drugs. The company was founded by Ms Khaldi, a TCD-trained mathematician and bioinformatics specialist, in 2014 and was subsequently spun out of NovaUCD’s VentureLaunch accelerator programme.
Read more: http://bit.ly/2GfOBWd
